ALOX12 and colorectal carcinoma: In order to explore the relationship between ALOX5, FLAP, ALOX12 and ALOX15 polymorphisms and CRC risk, a U.S. cohort analysis found that genetic variants in ALOXs may affect the risk of colorectal tumor development and alter the protective effect of NSAID use on CRC 98.